Suspected Spinal Epidural Abscess
Back pain + fever +/- neurological symptoms
All Pathways
NeurosurgeryEmergency
Spinal Epidural Abscess - Surgical Decision Making (IDSA 2015)
Spinal Epidural Abscess - Surgical Decision Making (IDSA 2015): Suspected Spinal Epidural Abscess → Assess Clinical Triad → Identify Risk Factors → URGE...
Pathway Overview
16 steps
Algorithm Steps
16 total
01Start 02Action Assess Clinical Triad
Classic triad present in <15% of cases
- 1. Back pain (most common, 70-90%)
- 2. Fever (60-70%)
- 3. Neurological deficit (35-50%)
- Full triad in only 10-15%
- HIGH INDEX OF SUSPICION required
03Action Identify Risk Factors
Most patients have predisposing conditions
- Diabetes mellitus (most common)
- IV drug use
- Recent spinal procedure/epidural
- Immunocompromised state
- Chronic kidney disease
- Recent bacteremia/endocarditis
- Adjacent infection (psoas, retroperitoneal)
04Action URGENT MRI Whole Spine
MRI with gadolinium - DO NOT DELAY
- MRI is gold standard (>90% sensitivity)
- T1: hypointense epidural mass
- T2: hyperintense signal
- Contrast: peripheral rim enhancement
- May extend multiple levels
- CT myelogram only if MRI contraindicated
05Decision Neurological Status?
Motor function determines urgency
06Warning Neurological Deficit Present
SURGICAL EMERGENCY
- Motor weakness (any grade)
- Sensory level
- Bowel/bladder dysfunction
- Rapid progression (hours)
- Surgery within 24-48h improves outcomes
- Paralysis >48-72h often irreversible
07Action Emergency Surgical Decompression
Laminectomy + abscess drainage
- Posterior laminectomy (most common)
- Evacuate purulent material
- Cultures: aerobic, anaerobic, fungal, TB
- Debride infected tissue
- May need fusion if instability
- Drain placement optional
08Action Empiric Antibiotic Therapy
Start IMMEDIATELY - do not wait for cultures
- Vancomycin 15-20 mg/kg IV q8-12h (target trough 15-20)
- PLUS Cefepime 2g IV q8h OR Meropenem 2g IV q8h
- Add Metronidazole if anaerobes suspected
- S. aureus most common (60-70%)
- GNR in IVDU/UTI source
- Duration: 6-8 weeks IV (IDSA)
09Action Source Identification & Control
Find and treat primary source
- Blood cultures x2 before antibiotics
- TTE/TEE if endocarditis suspected
- Dental evaluation
- Skin/soft tissue infection
- UTI source workup
- Remove infected hardware if present
10Action Culture-Directed Therapy
Narrow antibiotics based on results
- MSSA: Nafcillin/Oxacillin 2g IV q4h
- MRSA: Continue Vancomycin
- Streptococcus: Penicillin G or Ceftriaxone
- GNR: Based on sensitivities
- TB: RIPE therapy
- Negative cultures: continue empiric
11Action Monitoring & Follow-up
Track response to therapy
- CRP/ESR trending down expected
- Repeat MRI at 4-6 weeks (or sooner if concern)
- Neuro exams daily initially
- Watch for surgical complications
- Transition to oral controversial
12Outcome Outcomes
Prognosis depends on pre-op neuro status
- Best outcomes: surgery before deficits develop
- Paralysis >24-48h: poor recovery
- Mortality: 5-15%
- Permanent deficits: 15-40%
- Recurrence: 5-10%
13Action No Neurological Deficit
May consider medical management
- Pain only (no weakness)
- Intact motor function
- Intact bowel/bladder
- Small abscess (<2.5 cm)
- Close monitoring MANDATORY
14Decision Medical Management Criteria Met?
All must be present
- No neurological deficit
- No significant instability
- Pathogen identified (blood/aspirate)
- No large compressive collection
- Patient can be monitored closely
15Action Medical Management
IV antibiotics + close monitoring
- CT-guided aspiration for culture
- Serial neuro exams q4-6h initially
- Repeat MRI at 2-4 weeks
- Convert to surgery if deterioration
- Total duration 6-8 weeks IV
- Path rejoins step 08Shared downstream outcome
16Warning Warning: Any Deterioration
Convert to surgical management
- New or worsening weakness
- Progression on imaging
- Failure to improve by 48-72h
- Increasing inflammatory markers
- Hemodynamic instability
- Path rejoins step 07Shared downstream outcome
- Path rejoins step 07Shared downstream outcome
Guideline Source
IDSA Clinical Practice Guidelines for Native Vertebral Osteomyelitis + StatPearls Epidural Abscess
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Optimal timing of surgery remains debated (earlier better)
- IDSA 2015 excludes SEA without NVO - based on literature review
- Pediatric presentations may differ
- Immunocompromised patients need modified approach
- Local antibiogram should guide therapy
Applicable Regions
USEU
EU: Similar approach, local resistance patterns vary
US: IDSA 2015 + local antibiogram
Version 1Next review: 2027-01-11
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Spinal Epidural Abscess - Surgical Decision Making (IDSA 2015)?
The Spinal Epidural Abscess - Surgical Decision Making (IDSA 2015) is a emergency clinical algorithm for Neurosurgery. It provides a structured decision tree to guide clinical decision-making, based on IDSA Clinical Practice Guidelines for Native Vertebral Osteomyelitis + StatPearls Epidural Abscess.
What guideline is the Spinal Epidural Abscess - Surgical Decision Making (IDSA 2015) based on?
This algorithm is based on IDSA Clinical Practice Guidelines for Native Vertebral Osteomyelitis + StatPearls Epidural Abscess (DOI: 10.1093/cid/civ482).
What are the limitations of the Spinal Epidural Abscess - Surgical Decision Making (IDSA 2015)?
Known limitations include: Optimal timing of surgery remains debated (earlier better); IDSA 2015 excludes SEA without NVO - based on literature review; Pediatric presentations may differ; Immunocompromised patients need modified approach; Local antibiogram should guide therapy. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Spinal Epidural Abscess - Surgical Decision Making (IDSA 2015) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free